Literature DB >> 6212008

Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing.

W A Altemeier, S A Lewis, P M Schlievert, M S Bergdoll, H S Bjornson, J L Staneck, B A Crass.   

Abstract

Phage type 29 Staphylococcus aureus was identified singly or with type 52 in 64.1% of 248 coded isolates from patients with toxic shock syndrome. These phage types also have a high capability of producing pyrogenic exotoxin C and enterotoxin F. The origin and development of these toxigenic strains were explored by studying 25,220 isolates of S. aureus stored in a staphylococcal bank between 1960 and 1979. A small percentage of phage types 29, 52 were found in 1960, but their prevalence increased between 1961 and 1970, and continued at elevated levels through 1979. The toxigenic capabilities of these phage types were apparently acquired about 1971 and increased up to 1975. High levels of prevalence persisted during the following 4 years, and receded in 1980 and 1981. Other evidence during 1980 and 1981 indicates that these strains of S. aureus have become an important pathogen in surgical wounds, burns, and other infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6212008     DOI: 10.7326/0003-4819-96-6-978

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  24 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1.

Authors:  G Ho; W H Campbell; E Carlson
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Involvement of coagulase-negative staphylococci in toxic shock syndrome.

Authors:  B A Crass; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Toxic shock syndrome in a penicillin sensitive patient.

Authors:  M Barry; P Mac Mathúna; J C de Azavedo; J Feely
Journal:  Ir J Med Sci       Date:  1987-01       Impact factor: 1.568

5.  Staphylococcus aureus--toxic shock syndrome toxin-1 antibody titers in serum of German women.

Authors:  E G Loch; B A Crass; M S Bergdoll
Journal:  Arch Gynecol       Date:  1986

Review 6.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  J K Todd; A Franco-Buff; D W Lawellin; M L Vasil
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

Review 8.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Studies on staphylococci from toxic shock syndrome in France, 1981-1983.

Authors:  A K Melconian; J Fleurette; Y Brun
Journal:  J Hyg (Lond)       Date:  1985-02

10.  [Special features of intensive care of toxic shock syndrome. Review and case report of a TSST-1 associated toxic-shock syndrome with adult respiratory distress syndrome and multiple organ failure from a staphylococcal panaritium].

Authors:  C Lang; H Behnke; J Bittersohl; L Eberhart; E Walthers; F Sommer; H Wulf; G Geldner
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.